Laboratory Field Services

CLINICAL LABORATORY TECHNOLOGY ADVISORY COMMITTEE BYLAWS

Jump to: Article I - Name and Purspose | Article II - Structure | Article III - Operational Procedures | CLTAC Homepage

Article I – Name and Purpose

Section A: Name

The name of this Committee shall be the Clinical Laboratory Technology Advisory Committee (CLTAC).

Section B: Purpose

Pursuant to Section 1228 of the Business and Professions Code, the purpose of the Committee is to assist, advise, and make recommendations to the California Department of Public Health (Department) for the establishment of rules and regulations necessary to ensure proper administration and enforcement of Chapter 3 of Division 2 of the California Business and Professions Code (Chapter 3) and Chapters 4 and 4.1 of Division 2 of the Health and Safety Code (HSC Chapters 4 and 4.1). The Committee also advises the Department on matters concerning examinations for licensees under Chapter 3 and HSC Chapters 4 and 4.1 and provides technical expertise related to clinical laboratory technology and practice.

Article II – Structure

Section A: Number of Appointment and Members

The Committee shall consist of five (5) voting members appointed by the Director of the Department from nominees solicited by the Department. Non-voting consultants may be appointed as necessary. Appointments shall be made in time for terms to begin January 1, with nominations submitted sixty (60) days prior to term expiration.

Section B: Vacancies

The Department shall initiate to appoint a replacement Committee member within sixty (60) days to complete any unexpired term.

Section C: Conflict of Interest

As a condition of participating as a Committee member of CLTAC, all voting members shall complete the Statement of Economic Interests Form 700 and any related attachments pursuant to the requirements of the California Fair Political Practices Commission upon assuming office, annually, and upon leaving office.

Section D: Membership

The Department may solicit nominees from organizations representing key stakeholders that provide representation of all persons that are affected by clinical laboratory laws, including, but not limited to:

Educational institutions Hospitals and health systems
Independent/reference laboratories
Professional associations
Biotech and diagnostic innovators

Each organization may submit up to two (2) nominees.

Section E: Term

Terms shall be four (4) years. Committee members may not serve more than two consecutive terms until replaced (no more than sixty (60) days), with their consent. Department representatives serve ex officio and act as Secretary. Committee members serve without compensation or reimbursement.

Section F: Chair and Vice Chair

The Committee shall elect a Chair and Vice Chair biannually to serve two-year terms. The Chair facilitates meetings; the Vice Chair presides in the Chair’s absence.

Article III – Operational Procedures

Section A: Voting Rights

Each voting member has one vote. Decisions require a majority vote.

Section B: Quorum

A quorum is defined per Government Code Section 11123.5(e). No official action may be taken without a quorum.

Section C: Meetings

Meetings shall follow the Bagley-Keene Open Meeting Act (Article 9, Chapter 1, Part 1, Division 3 of Title 2 of the Government Code) (Bagley-Keene Act). If the provisions of these bylaws are in conflict with the Bagley-Keene Act or its interpretation in law, the Bagley-Keene Act and/or its interpretation in law shall supersede these bylaws.

Meeting Frequency
The Committee shall meet annually or as needed with Department approval.
Notice Requirements
The Department shall provide public notice of meetings at least ten (10) calendar days in advance, including date, time, location, and agenda.
Public Access
All meetings shall comply with the Bagley-Keene Act.
Interim Communications
The Chair or Department may solicit input between meetings. Such input is not official unless confirmed at a meeting with quorum.
Agenda Development
The Department and each CLTAC member shall be invited to submit agenda items before each scheduled meeting.
Bagley-Keene Act
If any of these subsections conflict with the Bagley-Keene Act or its interpretation in law, the Bagley-Keene Act and/or its interpretation in law shall supersede these bylaws.

Section D: Subcommittees

Establishment and Purpose
Subcommittees may be established by the Department to address specific tasks. The findings shall be shared with the full CLTAC Committee.
Membership and Appointment
Subcommittee members and subcommittee Chair are appointed by the CLTAC Committee Chair in consultation with and approval by the Department. Chairs must be voting CLTAC members. Non-members may serve.
Voting Authority
Only appointed subcommittee members may vote. Subcommittee votes are advisory unless authority is delegated by the CLTAC Committee with approval by the Department.
Compliance with Bagley-Keene Open Meeting Act
Subcommittees that:

Consist of three (3) or more Committee members, or
Are formally created by the Committee must comply with Bagley-Keene requirements.

Attendance and Participation
Committee members not on the subcommittee may attend as observers only.
Meeting Notices
Notices shall be posted on the Laboratory Field Services website.
Exemptions
Ad hoc advisory groups composed of less than a quorum and not formally created may be exempt from Bagley-Keene.Section E: Consultants

Section E: Consultants

The Committee or Department may invite consultants to present or participate in discussions at the Chair’s discretion or by majority vote and pursuant to the Department’s approval. This shall be included as part of the agenda.

Section F: Minutes

The Department staff shall record Committee actions. Approved minutes shall be made available to members and the public.

Section G: Amendment of Bylaws

These Bylaws may be amended or repealed upon approval by the Director of the Department. A majority of the voting members at a duly constituted public meeting may recommend to the Director that these Bylaws be adopted, amended or repealed. 

In the event a statutory or regulatory change modifies the function, composition or other aspect of CLTAC, the change(s) will be incorporated into these Bylaws by the Department staff and presented to CLTAC at the next meeting for recommendations to the Director.